1 |
Mathers CD, Vos ET, Stevenson CE, Begg SJ. 2000. The Australian Burden of Disease study: measuring the loss of health from diseases, injuries and risk factors. Med J Australia 172: 592-596
|
2 |
Reddy KS, Yushf S. 1998. Emerging epidemic of cardiovascular disease in developing countries. Circulation 97: 596- 601
DOI
ScienceOn
|
3 |
Miura K, Takeda R, Nakamoto H, Saito H. 1971. The chemical and pharmacological study of Puerariae Radix. J Appl Pharmacol 5: 247-252
|
4 |
Lee JS, Lee KH, Jeong JH. 1999. Effects of extract of Pueraria radix on lipid metabolism in rats fed high fat diet J Korean Soc Food Sci Nutr 28: 218-224
|
5 |
Murayama T, Yokode M, Horiuchi H, Yoshida H, Sano H, Kita T. 2000. Overexpression of low density lipoprotein receptor eliminates apolipoprotein B100-containing lipoproteins from circulation and markedly prevents early atherogenesis in apolipoprotein E-deficient mice. Atherosclerosis 153: 295-302
DOI
ScienceOn
|
6 |
Sniderman AD, Cianflone K. 1993. Substrate delivery as a determinant of hepatic apo B secretion. Arterioscl Thromb Vass Biol 13: 629-636
DOI
|
7 |
Isherwood SG, Williams CM, Gould BJ. 1997. Apolipoprotein B-48 as a marker for chylomicrons and their remnants: studies in the postprandial state. Proceed Nutr Soc 56: 497-505
DOI
|
8 |
Mamo JCL. 1995. Atherosclerosis as a post-prandial disease. Endocrinol Metab 2: 229-244
|
9 |
Winkler K, Schafer JR, Klima B, Nuber C, Sattler A, Friedrich I, Koster W, Steinmetz A, Wieland H, Marz W. 1999. Lifibrol enhances the low density lipoprotein apolipoprotein B-100 turnover in patients with hypercholesterolemia and mixed hyperlipidemia. Atherosclerosis 144: 167- 175
|
10 |
Kang S, Davis RA. 2000. Cholesterol and hepatic lipoprotein assembly and secretion. Mol Cell Biol Lipid 1529: 223-230
DOI
ScienceOn
|
11 |
Havel R. 1994. Triglyceride-rich lipoproteins and atherosclerosis-new perspectives. J Nutr 59: 795-799
|
12 |
Lee JS, Kim ES. 1999. Effedcts of Pueraria lobata extract on ADH and ALDH activities in ethanol administered rats. The Kosin J Health Sciences 9: 17-23
|
13 |
Hussain MM, Kanch RK, Zhou Z, Luchoomun J, Zu H, Bakillah A. 1996. Chylomicron assembly and catabolism: role of apolipoproteins and receptors. Biochim Biophy Acta 1300: 151-170
DOI
ScienceOn
|
14 |
Guerra MC, Speroni E, Broccoli M, Cangini M, Pasini P, Minghetti A, Crespi-Perellino N, Mirasoli M, Cantelli-Forti G, Paolini M. 2000. Comparison between Chinese medical herb Pueraria lobata crude extract and its main isoflavone puerarin antioxidant properties and effects on rat liver CYP- catalysed drug metabolism. Life Sciences 67: 2997-3006
DOI
ScienceOn
|
15 |
Lee JS, Kim ES, Kim SW. 1999. Effects of extract of Pueraria radix on lipid peroxidation in ethanol-administered rats. J Korean Soc Food Sci Nutr 28: 901-906
|
16 |
Levy E, Mehran M, Seidman E. 1995. Caco-2 cells as a model for intestinal lipoprotein synthesis and secretion. FASEB J 9: 626-635
|
17 |
Lowry OH, Rosebroug NJ, Farr AL, Rendall RJ. 1951. Protein measurement with folin phenol reagent. J Biol Chem 193: 265-270
|
18 |
Karmin O, Lynn EG, Chung YH, Siow YL, Man RYK, Choy PC. 1998. Homocysteine stimulates the production and secretion of cholesterol in hepatic cells. Biochim Biophy Acta 1393: 317-324
DOI
ScienceOn
|
19 |
Cumminngs MH, Watts GF. 1995. Increased hepatic secretion of low density lipoprotein apo B100 in cholesterol ester storage disease. Clin Chem 41: 111-115
|
20 |
Watts GG, Naoumova R, Cumminngs MH, Umpleby AM, Slavin BM, Sonksen PH, Thompson GR. 1995. Direct correlation between cholesterol synthesis and secretion of apolipoprotein B-100 in normolipemic subject. Metabolism 44: 1052-1059
DOI
ScienceOn
|
21 |
Burnett JR, Wilcox JL, Telford DE, Kleinstiver SJ, Barett PH, Newton RS, Huff MW. 1997. Inhibition of HMG-CoA reductase by atorvastatin decreases both VLDL and LDL apolipoprotein B production in miniature pigs. Arterioscle Thromb Vasc Biol 17: 2589-2600
DOI
ScienceOn
|
22 |
Redgrave TG. 1983. Formation and metabolism of chylomicrons. Int Rev Physiol 28: 103-113
|